It is only obvious that Allergan wants to control everything. I am personally thrilled that Medicis is coming out with a Botox-like product. RevitaLash is hanging in there -- they changed their formulation slightly to NOT include a bimatoprost from my understanding are NOT going to bow down like the other's have. Kudos To RevitaLash for standing up to the big dogs. As if an ophthalmologist is going to create dangerous to the eyes.
Since Allergan is practically eating up every small profitable derm business out there, I personally hope the the other eyelash companies stand tall. Who wants to buy a prescriptive for almost the same thing that is aready out there and pay $50 more a tube. I don't care if the non-prescriptive takes a week longer to work....
Recent comments
Posted to Allergan to cash in on lash enhancer on 18 Nov 2008